Top

International Journal of Diabetes in Developing Countries

Published in:

01-04-2019 | Original Article

Influence of non-surgical periodontal therapy on insulin resistance in chronic periodontitis subjects with prediabetes

Authors: Shravani Babladi, Rupali Agnihotri, Pratibha Gopalkrishna, Shobha U. Kamath, Sushma Jogi, Brunda Arun

Published in: International Journal of Diabetes in Developing Countries | Issue 2/2019

Abstract

Prediabetes (PRD) has been closely associated with chronic periodontitis (CP). Lately, studies have proposed the role of glutathione peroxidase (GPx), a ubiquitous antioxidant, in potentiating insulin resistance (IR), a significant factor in PRD. As overexpression of GPx is associated with CP as well as IR, the current study was undertaken to evaluate the influence of non-surgical periodontal therapy (NSPT) on GPx levels and hence the IR in CP subjects with PRD. Forty-seven subjects were divided into two major groups: healthy controls (n = 11) and CP (n = 36), according to probing depth (PD) and clinical attachment loss (CAL). The CP patients were subdivided into CP only (n = 18) and CP with PRD (n = 18) based on baseline FBS levels. Serum and crevicular GPx and malondialdehyde (MDA) were measured in all the subjects using spectrophotometry. The participants underwent NSPT at baseline and 3 months. At 6 months, all the parameters were re-recorded. At 6 months after NSPT, there was significant improvement in periodontal health (p < 0.05) in all the three groups which was associated with reduced GPx and MDA levels. Besides, a significant reduction in IR was noted in both CP and CP with PRD groups (p < 0.05). NSPT may be a vital tool in reducing IR in CP subjects with PRD. This was clearly evident as there was progressive decline in IR with GPx levels along with improvement in other parameters, specifically in the PRD group.

Tonetti MS, Claffey N. Advances in the progression of periodontitis and proposal of definitions of a periodontitis case and disease progression for use in risk factor research. J Clin Periodontol. 2005;32:210–3.CrossRefPubMed

Löe H. Periodontal disease: the sixth complication of diabetes mellitus. Diabetes Care. 1993;16:329–34.CrossRefPubMed

Grossi SG, Genco RJ. Periodontal disease and diabetes mellitus: a two-way relationship. Ann Periodontol. 1998;3:51–61.CrossRefPubMed

Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160–7.CrossRefPubMed

American Diabetes Association. 2. Classification and diagnosis of diabetes. Diabetes Care. 2017; https://doi.org/10.2337/dc17-S005.

Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. Prediabetes: a high-risk state for developing diabetes. Lancet. 2012;379:2279–90.CrossRefPubMedPubMedCentral

Choi YH, McKeown RE, Mayer-Davis EJ, Liese AD, Song KB, Merchant AT. Association between periodontitis and impaired fasting glucose and diabetes. Diabetes Care. 2011;34:381–6.CrossRefPubMedPubMedCentral

Benguigui C, Bongard V, Ruidavets JB, Chamontin B, Sixou M, Ferrières J, et al. Metabolic syndrome, insulin resistance, and periodontitis: a cross-sectional study in a middle-aged French population. J Clin Periodontol. 2010;37:601–8.CrossRefPubMed

Nishimura F, Murayama Y. Periodontal inflammation and insulin resistance-lessons from obesity. J Dent Res. 2001;80:1690–4.CrossRefPubMed

10.

Nibali L, D’Aiuto F, Griffiths G, Patel K, Suvan J, Tonetti MS. Severe periodontitis is associated with systemic inflammation and a dysmetabolic status: a case-control study. J Clin Periodontol. 2007;34:931–7.CrossRefPubMed

11.

Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Tumor necrosis factor alpha inhibits signaling from the insulin receptor. Proc Natl Acad Sci U S A. 1994;91:4854–8.CrossRefPubMedPubMedCentral

12.

Ogihara T, Asano T, Katagiri H, Sakoda H, Anai M, Shojima N, et al. Oxidative stress induces insulin resistance by activating the nuclear factor-kappa B pathway and disrupting normal subcellular distribution of phosphatidylinositol 3-kinase. Diabetologia. 2004;47:794–805.CrossRefPubMed

13.

Pryor WA, Godber SS. Noninvasive measures of oxidative stress status in humans. Free Radic Biol Med. 1991;10:177–84.CrossRefPubMed

14.

Schmidt AM, Weidman E, Lalla E, Yan S, Hori O, Cao R, et al. Advanced glycation end products (AGEs) induce oxidant stress in the gingiva: a potential mechanism underlying accelerated periodontal disease associated with diabetes. J Periodontal Res. 1996;31:508–15.CrossRefPubMed

15.

Holmstrom KM, Finkel T. Cellular mechanisms and physiological consequences of redox-dependent signalling. Nat Rev Mol Cell Biol. 2014;15:411–21.CrossRefPubMed

16.

Lubos E, Loscalzo J, Handy DE. Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal. 2011;15:1957–97.CrossRefPubMedPubMedCentral

17.

Mc Clung JP, Roneker CA, Mu W, et al. Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase. Proc Natl Acad Sci U S A. 2004;101:8852–7.CrossRef

18.

Chen X, Scholl TO, Leskiw MJ, Donaldson MR, Stein TP. Association of glutathione peroxidase activity with insulin resistance and dietary fat intake during normal pregnancy. J Clin Endocrinol Metab. 2003;88:5963–8.CrossRefPubMed

19.

Duarte PM, Napimoga MH, Fagnani EC, Santos VR, Bastos MF, Ribeiro FV, et al. The expression of antioxidant enzymes in the gingivae of type 2 diabetics with chronic periodontitis. Arch Oral Biol. 2012;57:161–8. https://doi.org/10.1016/j.archoralbio.2011.08.007.CrossRefPubMed

20.

Patel SP, Pradeep AR, Chowdhry S. Crevicular fluid levels of plasma glutathione peroxidase (eGPx) in periodontal health and disease. Arch Oral Biol. 2009;54:543–8. https://doi.org/10.1016/j.archoralbio.2009.02.002.CrossRefPubMed

21.

Panjamurthy K, Manoharan S, Ramachandran CR. Lipid peroxidation and antioxidant status in patients with periodontitis. Cell Mol Biol Lett. 2005;10:255–64.PubMed

22.

Silness J, Löe H. Periodontal disease in pregnancy II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand. 1964;22:121–35.CrossRefPubMed

23.

Löe H, Silness J. Periodontal disease in pregnancy I. Prevalence and severity. Acta Odontol Scand. 1963;21:533–51.CrossRefPubMed

24.

Loe H, Holm-Pedersen P. Absence and presence of fluid from normal and inflamed gingivae. Periodontics. 1965;149:171–7.

25.

Wendel A. Enzymatic basis of detoxication. New York: Academic Press; 1980.

26.

Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta. 1978;90:37–43.CrossRefPubMed

27.

Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.CrossRefPubMed

28.

Pattison AM, Pattison GL. Scaling and root planing. In: Newman MG, Takei HH, Klokkevolg PR, Carranza FA, editors. Carranza’s clinical periodontology. Missouri: Saunders; 2006. p. 749–97.

29.

Sullivan GM, Feinn R. Using effect size—or why the P value is not enough. J Grad Med Educ. 2012;4:279–82.CrossRefPubMedPubMedCentral

30.

Saito T, Shimazaki Y, Kiyohara Y, Kato I, Kubo M, Iida M, et al. Relationship between obesity, glucose tolerance, and periodontal disease in Japanese women: the Hisayama study. J Periodontal Res. 2005;40:346–53.CrossRefPubMed

31.

Demmer RT, Jacobs DR Jr, Singh R, Zuk A, Rosenbaum M, Papapanou PN, et al. Periodontal bacteria and prediabetes prevalence in ORIGINS: the oral infections, glucose intolerance, and insulin resistance study. J Dent Res. 2015;94:201S–11S. https://doi.org/10.1177/0022034515590369.CrossRefPubMedPubMedCentral

32.

Vergnes JN. Treating periodontal disease may improve metabolic control in diabetics. Evid Based Dent. 2010;11:73–4.CrossRefPubMed

33.

Borrell LN, Kunzel C, Lamster I, Lalla E. Diabetes in the dental office: using NHANES III to estimate the probability of undiagnosed disease. J Periodontal Res. 2007;42:559–65.CrossRefPubMed

34.

Geerts SO, Nys M, De MP, et al. Systemic release of endotoxins induced by gentle mastication: association with periodontitis severity. J Periodontol. 2002;73:73–8.CrossRefPubMed

35.

Pham-Huy LA, He H, Pham-Huy C. Free radicals, antioxidants in disease and health. Int J Biomed Sci. 2008;4:89–96.PubMedPubMedCentral

36.

Bajaj S, Khan A. Antioxidants and diabetes. Indian J Endocrinol Metab. 2012; https://doi.org/10.4103/2230-8210.104057.

37.

Gaurav AN. Periodontitis and insulin resistance: casual or causal relationship? Diabetes Metab J. 2012;36:404–11.CrossRef

38.

Blasco-Baque V, Garidou L, Pomié C, Escoula Q, Loubieres P, le Gall-David S, et al. Periodontitis induced by Porphyromonas gingivalis drives periodontal microbiota dysbiosis and insulin resistance via an impaired adaptive immune response. Gut. 2017;66:872–85.CrossRefPubMed

39.

Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56:1761–72.CrossRefPubMed

40.

Amar J, Burcelin R, Ruidavets JB, Cani PD, Fauvel J, Alessi MC, et al. Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr. 2008;87:1219–23.CrossRefPubMed

41.

Kolb H, Eizirik DL. Resistance to type 2 diabetes mellitus: a matter of hormesis? Nat Rev Endocrinol. 2012;8:183–92.CrossRef

42.

Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860–7.CrossRefPubMed

43.

Nicholson JK, Holmes E, Kinross J, Burcelin R, Gibson G, Jia W, et al. Host-gut microbiota metabolic interactions. Science. 2012;336:1262–7.CrossRefPubMed

44.

Burcelin R, Garidou L, Pomié C. Immuno-microbiota cross and talk: the new paradigm of metabolic diseases. Semin Immunol. 2012;24:67–74.CrossRefPubMed

45.

Watanabe K, Petro BJ, Shlimon AE, Unterman TG. Effect of periodontitis on insulin resistance and the onset of type 2 diabetes mellitus in Zucker diabetic fatty rats. J Periodontol. 2008;79:1208–16.CrossRefPubMed

46.

Wilcox G. Insulin and insulin resistance. Clin Biochem Rev. 2005;26:19–39.PubMedPubMedCentral

47.

Tüzün A, Erdil A, Inal V, Aydin A, Bağci S, Yeşilova Z, et al. Oxidative stress and antioxidant capacity in patients with inflammatory bowel disease. Clin Biochem. 2002;35:569–72.CrossRefPubMed

48.

Wingler K, Hermans JJ, Schiffers P, Moens A, Paul M, Schmidt HH. NOX1, 2, 4, 5: counting out oxidative stress. Br J Pharmacol. 2011;164:866–83.CrossRefPubMedPubMedCentral

49.

Zhang X, Min X, Li C, Benjamin IJ, Qian B, Zhang X, et al. Involvement of reductive stress in the cardiomyopathy in transgenic mice with cardiac-specific overexpression of heat shock protein 27. Hypertension. 2010;55:1412–7.CrossRefPubMed

50.

Rajasekaran NS, Connell P, Christians ES, Yan LJ, Taylor RP, Orosz A, et al. Human alpha B-crystallin mutation causes oxido-reductive stress and protein aggregation cardiomyopathy in mice. Cell. 2007;130:427–39.CrossRefPubMedPubMedCentral

51.

Patel SP, Rao NS, Pradeep AR. Effect of nonsurgical periodontal therapy on crevicular fluid and serum glutathione peroxidase levels. Dis Markers. 2012;32:1–7.CrossRefPubMedPubMedCentral

52.

Matés JM, Pérez-Gómez C, Núñez de Castro I. Antioxidant enzymes and human diseases. Clin Biochem. 1999;32:595–603.CrossRefPubMed

53.

Wang H, Zhou H, Duan X. Porphyromonas gingivalis-induced reactive oxygen species activate JAK2 and regulate production of inflammatory cytokines through c-Jun. Infect Immun. 2014;82:4118–26.CrossRefPubMedPubMedCentral

54.

Choi CH, Spooner R, DeGuzman J, Koutouzis T, Ojcius DM, Yilmaz Ö. Porphyromonas gingivalis-nucleoside-diphosphate-kinase inhibits ATP-induced reactive-oxygen-species via P2X7 receptor/NADPH-oxidase signaling and contributes to persistence. Cell Microbiol. 2013;15:961–76.CrossRefPubMedPubMedCentral

55.

Kaji H, Kurasaki M, Ito K, Saito T, Saito K, Niioka T, et al. Increased lipoperoxide value and glutathione peroxidase activity in blood plasma of type 2 (non-insulin-dependent) diabetic women. Klin Wochenschr. 1985;63:765–8.CrossRefPubMed

56.

Brock GR, Butterworth CJ, Matthews JB, Chapple IL. Local and systemic total antioxidant capacity in periodontitis and health. J Clin Periodontol. 2004;31:515–21.CrossRefPubMed

57.

Javed F, Thafeed AlGhamdi AS, Mikami T, et al. Effect of glycemic control on self-perceived oral health, periodontal parameters, and alveolar bone loss among patients with prediabetes. J Periodontol. 2014;85:234–41.CrossRefPubMed

58.

Andriankaja OM, Joshipura K. Potential association between prediabetic conditions and gingival and/or periodontal inflammation. J Diabetes Investig. 2014;5:108–14.CrossRefPubMed

59.

Javed F, Ahmed HB, Mehmood A, Bain C, Romanos GE. Effect of nonsurgical periodontal therapy (with or without oral doxycycline delivery) on glycemic status and clinical periodontal parameters in patients with prediabetes: a short-term longitudinal randomized case–control study. Clin Oral Investig. 2014;18:1963–8.CrossRefPubMed

60.

Dağ A, Fırat ET, Arıkan Ş, Kadiroğlu AK, Kaplan A. The effect of periodontal therapy on serum TNF-α and HbA1c levels in type 2 diabetic patients. Aust Dent J. 2009;54:17–22.CrossRefPubMed

61.

D’aiuto F, Nibali L, Parkar M, Patel K, Suvan J, Donos N. Oxidative stress, systemic inflammation, and severe periodontitis. J Dent Res. 2010;89:1241–6.CrossRefPubMedPubMedCentral

62.

Katz J, Flugelman MY, Goldberg A, Heft M. Association between periodontal pockets and elevated cholesterol and low density lipoprotein cholesterol levels. J Periodontol. 2002;73:494–500.CrossRefPubMed

63.

Ekuni D, Tomofuji T, Tamaki N, Sanbe T, Azuma T, Yamanaka R, et al. Mechanical stimulation of gingiva reduces plasma 8-OHdG level in rat periodontitis. Arc Oral Biol. 2008;53:324–9.CrossRef

64.

Renvert S, Wikström M, Dahlén G, Slots J, Egelberg J. Effect of root debridement on the elimination of Actinobacillus actinomycetemcomitans and Bacteroides gingivalis from periodontal pockets. J Clin Periodontol. 1990;17:345–50.CrossRefPubMed

65.

Sbordone L, Ramaglia L, Gulletta E, Iacono V. Recolonization of the subgingival microflora after scaling and root planing in human periodontitis. J Periodontol. 1990;61:579–84.CrossRefPubMed

66.

Simpson TC, Weldon JC, Worthington HV, et al. Treatment of periodontal disease for glycaemic control in people with diabetes mellitus. Cochrane Database Syst Rev. 2015;11:CD004714. https://doi.org/10.1002/14651858.CD004714.CrossRef

67.

Hendek MK, Erdemir EO, Kisa U, Ozcan G. Effect of initial periodontal therapy on oxidative stress markers in gingival crevicular fluid, saliva, and serum in smokers and non-smokers with chronic periodontitis. J Periodontol. 2015 Feb;86(2):273–82. https://doi.org/10.1902/jop.2014.140338.CrossRefPubMed

68.

Mizuno H, Ekuni D, Maruyama T, Kataoka K, Yoneda T, Fukuhara D, et al. The effects of non-surgical periodontal treatment on glycemic control, oxidative stress balance and quality of life in patients with type 2 diabetes: a randomized clinical trial. PLoS One. 2017;12(11):e0188171. https://doi.org/10.1371/journal.pone.0188171.CrossRefPubMedPubMedCentral

69.

Savini I, Catani MV, Evangelista D, Gasperi V, Avigliano L. Obesity-associated oxidative stress: strategies finalized to improve redox state. Int J Mol Sci. 2013;14:10497–538.CrossRefPubMedPubMedCentral

70.

Janket SJ, Wightman A, Baird AE, Van Dyke TE, Jones JA. Does periodontal treatment improve glycemic control in diabetic patients? A meta-analysis of intervention studies. J Dent Res. 2005;84:1154–9.CrossRefPubMed

71.

Sun WL, Chen LL, Zhang SZ, Wu YM, Ren YZ, Qin GM. Inflammatory cytokines, adiponectin, insulin resistance and metabolic control after periodontal intervention in patients with type 2 diabetes and chronic periodontitis. Intern Med. 2011;50:1569–74.CrossRefPubMed

Title: Influence of non-surgical periodontal therapy on insulin resistance in chronic periodontitis subjects with prediabetes
Authors: Shravani Babladi
Rupali Agnihotri
Pratibha Gopalkrishna
Shobha U. Kamath
Sushma Jogi
Brunda Arun
Publication date: 01-04-2019
Publisher: Springer India
Published in: International Journal of Diabetes in Developing Countries / Issue 2/2019
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI: https://doi.org/10.1007/s13410-018-0682-6

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2019

Prevalence of diabetic micro vascular complications at a tertiary care unit of Karachi, Pakistan

Should we still collect blood glucose sampling in fluoride tubes? An evidence-based study

Clinical and biochemical characteristics and the association of angiotensin type 1 receptor with normoalbuminuric chronic kidney disease among South Indian type 2 diabetes population

Prevalence of thyroid disorders is not different in type 2 diabetes mellitus compared to nondiabetics in South India

Left atrial diameter is associated with target organ damage in patients with type 2 diabetes mellitus

Ferritin and serum iron as surrogate markers of poor glycemic control and microvascular complications in type 2 diabetes mellitus

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage